Literature DB >> 20185603

Clinical measures identify vitamin D deficiency in dialysis.

Ishir Bhan1, Sherri-Ann M Burnett-Bowie, Jun Ye, Marcello Tonelli, Ravi Thadhani.   

Abstract

BACKGROUND AND OBJECTIVES: Vitamin D deficiency (defined by serum levels of 25-hydroxyvitamin D) is common in patients with ESRD on hemodialysis, but risk factors are unknown. This study was conducted to determine whether routinely measured clinical and demographic parameters could identify dialysis patients who are vitamin D deficient. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: Nine-hundred eight patients with 25-hydroxyvitamin D levels were identified from the Accelerated Mortality on Renal Replacement (ArMORR) cohort of incident U.S. dialysis patients and were divided into training (60%) and validation (40%) sets. Predictive models were generated from routinely assessed clinical and demographic data in the training set using logistic regression modeling, neural networks, and decision trees with vitamin D deficiency as the dependent variable. Models underwent progressive variable reduction to identify the simplest model that remained predictive.
RESULTS: Seventy-nine percent of the population was vitamin D deficient (25-hydroxyvitamin D <30 ng/ml). Black race, female sex, winter season, and hypoalbuminemia (serum albumin < or =3.1 g/dl) were the strongest predictors of vitamin D deficiency. In the validation set, the presence of hypoalbuminemia and winter season increased the likelihood of vitamin D deficiency in black women (from 90% to 100%), black men (from 85% to 100%), white women (from 82% to 94%), and white men (from 66% to 92%).
CONCLUSIONS: Deficiency of 25-hydroxyvitamin D is nearly universal among patients with hypoalbuminemia initiating chronic hemodialysis in winter.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20185603      PMCID: PMC2827576          DOI: 10.2215/CJN.06440909

Source DB:  PubMed          Journal:  Clin J Am Soc Nephrol        ISSN: 1555-9041            Impact factor:   8.237


  50 in total

Review 1.  Statistical evaluation of prognostic versus diagnostic models: beyond the ROC curve.

Authors:  Nancy R Cook
Journal:  Clin Chem       Date:  2007-11-16       Impact factor: 8.327

2.  Association of activated vitamin D treatment and mortality in chronic kidney disease.

Authors:  Csaba P Kovesdy; Shahram Ahmadzadeh; John E Anderson; Kamyar Kalantar-Zadeh
Journal:  Arch Intern Med       Date:  2008-02-25

3.  Oral active vitamin D is associated with improved survival in hemodialysis patients.

Authors:  Manuel Naves-Díaz; Daniel Alvarez-Hernández; Jutta Passlick-Deetjen; Adrian Guinsburg; Cristina Marelli; Diego Rodriguez-Puyol; Jorge B Cannata-Andía
Journal:  Kidney Int       Date:  2008-07-16       Impact factor: 10.612

4.  Racial and seasonal differences in 25-hydroxyvitamin D detected in maternal sera frozen for over 40 years.

Authors:  Lisa M Bodnar; Janet M Catov; Katherine L Wisner; Mark A Klebanoff
Journal:  Br J Nutr       Date:  2008-04-23       Impact factor: 3.718

Review 5.  Vitamin D insufficiency/deficiency in gastrointestinal disorders.

Authors:  Daniel D Bikle
Journal:  J Bone Miner Res       Date:  2007-12       Impact factor: 6.741

6.  Vitamin D levels and patient outcome in chronic kidney disease.

Authors:  Pietro Ravani; Fabio Malberti; Giovanni Tripepi; Paola Pecchini; Sebastiano Cutrupi; Patrizia Pizzini; Francesca Mallamaci; Carmine Zoccali
Journal:  Kidney Int       Date:  2008-10-08       Impact factor: 10.612

7.  Association of oral calcitriol with improved survival in nondialyzed CKD.

Authors:  Abigail B Shoben; Kyle D Rudser; Ian H de Boer; Bessie Young; Bryan Kestenbaum
Journal:  J Am Soc Nephrol       Date:  2008-05-07       Impact factor: 10.121

8.  Vitamin D levels and early mortality among incident hemodialysis patients.

Authors:  M Wolf; A Shah; O Gutierrez; E Ankers; M Monroy; H Tamez; D Steele; Y Chang; C A Camargo; M Tonelli; R Thadhani
Journal:  Kidney Int       Date:  2007-08-08       Impact factor: 10.612

9.  Evidence for persistent vitamin D 1-alpha-hydroxylation in hemodialysis patients: evolution of serum 1,25-dihydroxycholecalciferol after 6 months of 25-hydroxycholecalciferol treatment.

Authors:  G Jean; J C Terrat; T Vanel; J M Hurot; C Lorriaux; B Mayor; C Chazot
Journal:  Nephron Clin Pract       Date:  2008-08-25

10.  Prevalence of vitamin D [25(OH)D] deficiency and effects of supplementation with ergocalciferol (vitamin D2) in stage 5 chronic kidney disease patients.

Authors:  Debra Blair; Laura Byham-Gray; Emily Lewis; Susan McCaffrey
Journal:  J Ren Nutr       Date:  2008-07       Impact factor: 3.655

View more
  35 in total

1.  Vitamin D status of children receiving chronic dialysis.

Authors:  Basema I Dibas; Bradley A Warady
Journal:  Pediatr Nephrol       Date:  2012-06-03       Impact factor: 3.714

Review 2.  Vitamin D supplementation in chronic kidney disease: a systematic review and meta-analysis of observational studies and randomized controlled trials.

Authors:  Praveen Kandula; Mirela Dobre; Jesse D Schold; Martin J Schreiber; Rajnish Mehrotra; Sankar D Navaneethan
Journal:  Clin J Am Soc Nephrol       Date:  2010-09-28       Impact factor: 8.237

3.  Low 25-hydroxyvitamin D levels and mortality in non-dialysis-dependent CKD.

Authors:  Sankar D Navaneethan; Jesse D Schold; Susana Arrigain; Stacey E Jolly; Anil Jain; Martin J Schreiber; James F Simon; Titte R Srinivas; Joseph V Nally
Journal:  Am J Kidney Dis       Date:  2011-08-04       Impact factor: 8.860

Review 4.  Effect of nutritional vitamin D preparations on parathyroid hormone in patients with chronic kidney disease.

Authors:  Chrysoula Pipili; Chrysostomos Dimitriadis; Nigar Sekercioglu; Joanne M Bargman; Dimitrios D Oreopoulos
Journal:  Int Urol Nephrol       Date:  2011-08-26       Impact factor: 2.370

5.  Active vitamin D and acute respiratory infections in dialysis patients.

Authors:  Yoshihiro Tsujimoto; Hideki Tahara; Tetsuo Shoji; Masanori Emoto; Hidenori Koyama; Eiji Ishimura; Tsutomu Tabata; Yoshiki Nishizawa; Masaaki Inaba
Journal:  Clin J Am Soc Nephrol       Date:  2011-05-26       Impact factor: 8.237

6.  The Likelihood of Self-reporting Balance Problems in Those With Advanced Chronic Kidney Disease, Slow Gait Speed, or Low Vitamin D.

Authors:  Jordan F Wickstrom; Harlan R Sayles; Laura A Graeff-Armas; Jennifer M Yentes
Journal:  J Ren Nutr       Date:  2018-12-21       Impact factor: 3.655

7.  Vitamin D and parathyroid hormone status in community-dwelling elderly patients with mild-to-moderate kidney impairment.

Authors:  Nipith Charoenngam; Sutin Sriussadaporn
Journal:  Int Urol Nephrol       Date:  2021-01-09       Impact factor: 2.370

8.  Low 25-hydroxyvitamin D levels and cognitive impairment in hemodialysis patients.

Authors:  Kamran Shaffi; Hocine Tighiouart; Tammy Scott; Kristina Lou; David Drew; Daniel Weiner; Mark Sarnak
Journal:  Clin J Am Soc Nephrol       Date:  2013-02-28       Impact factor: 8.237

9.  Hyponatremia, mineral metabolism, and mortality in incident maintenance hemodialysis patients: a cohort study.

Authors:  Sagar U Nigwekar; Julia Wenger; Ravi Thadhani; Ishir Bhan
Journal:  Am J Kidney Dis       Date:  2013-04-13       Impact factor: 8.860

10.  Vitamin D deficiency and mortality in patients receiving dialysis: the Comprehensive Dialysis Study.

Authors:  Shuchi Anand; Glenn M Chertow; Kirsten L Johansen; Barbara Grimes; Lorien S Dalrymple; George A Kaysen; Manjula Kurella Tamura
Journal:  J Ren Nutr       Date:  2013-07-19       Impact factor: 3.655

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.